Bilateral retinal vasculitis in a patient with systemic lupus erythematosus and its remission with rituximab therapy

Abstract

Severe retinal vasculitis is a rare, but potentially blinding, complication of patients with systemic lupus erythematosus (SLE). We describe here the first reported case of treating severe bilateral SLE-associated retinal vasculitis with the anti-CD20 monoclonal antibody rituximab, a drug which has established its role in rheumatoid arthritis and has shown promise in case series for the treatment of severe SLE that is unresponsive to other therapies. This case suggests that rituximab-induced B-cell depletion may provide an important new therapeutic option for refractory cases of this devastating ocular complication.

Keywords

lupus retinal vasculitis rituximab B-cell depletion therapy

Get full access to this article

View all access options for this article.

References

Denniston AK , Murray PI SLE and the eye. In: Tsokos GC , Gordon C , Smolen JS (eds), Systemic lupus erythematosus: a companion to rheumatology. Philadelphia, PA: Mosby; 2007.

Jabs DA , Fine SL , Hochberg MC Severe retinal vaso-occlusive disease in systemic lupus erythematous. Arch Ophthalmol 1986; 104: 558-563.

Asherson RA , Merry P. , Acheson JF , Harris EN , Hughes GR Antiphospholipid antibodies: A risk factor for occlusive ocular vascular disease in systemic lupus erythematosus and the ‘primary’ antiphospholipid syndrome. Ann Rheum Dis 1989; 48: 358-361.

Graham EM , Spalton DJ , Barnard RO , Garner A. , Russell RW Cerebral and retinal vascular changes in systemic lupus erythematosus. Ophthalmology 1985; 92: 444-448.

Quillen DA , Stathopoulos NA , Blankenship GW , Ferriss JA Lupus associated frosted branch periphlebitis and exudative maculopathy. Retina 1997; 17: 449-451.

Zink JM , Singh-Parikshak R. , Johnson CS , Zacks DN Hypopyon uveitis associated with systemic lupus erythematosus and antiphospholipid antibody syndrome. Graefes Arch Clin Exp Ophthalmol 2005; 243: 386-388.

Reynolds JA , Toescu V. , Yee CS , Prabu A. , Situnayake D. , Gordon C. Effects of rituximab on resistant SLE disease including lung involvement. Lupus 2009; 18: 67-73.

Lu TY , Ng KP , Cambridge G. , et al. A retrospective seven-year analysis of the use of B cell depletion therapy in systemic lupus erythematosus at University College London hospital: the first fifty patients. Arthritis Rheum 2009; 61: 482-487.

Sadreddini S. , Noshad H. , Molaeefard M. , Noshad R. Treatment of retinal vasculitis in Behçet’s disease with rituximab. Mod Rheumatol 2008 ; 18: 306-308.

10.

Edwards JC , Szczepanski L. , Szechinski J. , et al. Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis. N Engl J Med 2004 ; 350: 2572-2581.